Physician

Ruben Kalra, M.D., M.B.A

According to 2025 Medicare claims, Ruben Kalra, M.D., M.B.A (NPI: 1245228766) practices pain management in the San Rafael, CA market, with the plurality of this provider's patient population coming from Marin, CA. This provider's primary affiliated billing organization is BASS MEDICAL GROUP (NPI: 1154401941; TIN: 562605608) and primary practice location at 94925-1174. Kalra is affiliated with the Privia Quality Network Tennessee, LLC (ACO ID: A4943), participating under the MSSP model.

Kalra's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 545 traditional Medicare patients, billed 9,258 HCPCS/CPT codes, and received $414,654 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 369 prescription claims across 102 beneficiaries totaling $19,871 in drug costs, led by Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen). 2018 DME data shows 26 claims. Open Payments data shows 8 records totaling $340. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $164,621 to $19,871. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	361	11,666	$388,139
2016	455	11,535	$396,474
2017	447	11,260	$417,546
2018	480	9,833	$392,174
2019	476	8,686	$421,688
2020	417	6,873	$390,842
2021	619	9,414	$491,692
2022	676	10,904	$554,268
2023	726	10,138	$529,340
2024	545	9,258	$414,654

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	231	2,091	$164,621
2016	209	1,114	$73,888
2017	202	867	$63,104
2018	258	958	$90,625
2019	216	856	$63,606
2020	191	907	$73,508
2021	211	802	$64,311
2022	140	463	$30,868
2023	134	442	$25,115
2024	102	369	$19,871

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	26	26	$19,842
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	364	1,157	$115
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	203	648	$83
80307	Testing for presence of drug, by chemistry analyzers	153	271	$60
99484	Care management services for behavioral health conditions, 20 minutes or more clinical staff time directed by health care professional	217	682	$51
96372	Injection of drug or substance under skin or into muscle	126	371	$14

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	52	1,371	$1,829
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	43	1,183	$1,532
Buprenorphine Hcl	Buprenorphine Hcl	14	404	$1,348
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	11	299	$1,215
Lidocaine	Lidocaine	17	490	$1,000

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	8	$340	PAINTEQ LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ruben Kalra, M.D., M.B.A?

Tedicare shows public-source Medicare data for Ruben Kalra, M.D., M.B.A (NPI 1245228766), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ruben Kalra, M.D., M.B.A have ACO affiliation data?

Ruben Kalra, M.D., M.B.A is shown with ACO affiliation data for Privia Quality Network Tennessee, LLC (MSSP, ACO ID A4943).

What billing organization is linked to Ruben Kalra, M.D., M.B.A?

Ruben Kalra, M.D., M.B.A is linked to BASS MEDICAL GROUP (billing NPI 1154401941) in the available physician profile data.

Does Ruben Kalra, M.D., M.B.A have Open Payments data?

Ruben Kalra, M.D., M.B.A has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.